Menarini Biotech
Immacolata Longobardo is an experienced analytical development professional currently serving as the Analytical Development Team Leader at Menarini Biotech since September 2011, where responsibilities include analytical development planning and method validation in compliance with GMP and regulatory guidelines. Immacolata has a strong background in biochemistry and molecular biology, with previous roles including Analytical Development Team Coordinator and Research Technician focused on bioanalytical method development. Additional experience includes a brief role at QUALITY ASSISTANCE for technology transfer of Real-time PCR methods, and internships at CNR-IEOS and CNIC where expertise in molecular techniques and cardiovascular research was cultivated. Immacolata holds a Master’s degree in Medical Biotechnologies and a PhD in Molecular Medicine and Genetics from Università degli studi di Napoli Federico II.
This person is not in any teams
Menarini Biotech
4 followers
Menarini Biotech (“MBH”) is a fast-growing, agile, fully integrated CDMO for biologics located in the greater Rome area, Italy. Established in 2003, Menarini Biotech’s mission is to provide fast and efficient, yet very customer-centric, world-class, high-quality, services for biotech companies from preclinical development to GMP manufacturing (Mammalian and Microbial) up to BSL-2. These include CHO cell line development and analytical development for standard and non-standard mAbs, and new molecular formats, e.g. bispecifics, ADCs, fusion proteins. Our Quality System complies with AIFA/EU GMP requirements.